Medtronic Announces Separation From Diabetes Business, CEO Says it’s “In a Really Good Spot”

On Wednesday, Medtronic (NYSE:MDT) announced its intention to separate its diabetes business into a new, standalone company, to enhance focus on high-margin growth drivers for...

Keep Reading →